The primary objective is to establish whether ESP ropivacaine reduces post-operative opioid use and improves pain rating post-operatively. The secondary objectives include adverse event incidence, time to ambulation and time to discharge.
Prospective, single-centre, randomized, controlled, open-label, evaluator-blinded, superiority trial.